A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...

The primary market drivers focus on global business expansion. Additionally, the report presents trends, advancements, material insights, technological developments, and the evolving market structure.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

HB-adMSCs is under clinical development by Hope Biosciences and currently in Phase I for Primary Lateral Sclerosis. According to GlobalData, Phase I drugs for Primary Lateral Sclerosis does not have ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Its pipeline products include PIPE-791, an LPA1 receptor antagonist for idiopathic pulmonary fibrosis (IPF) and progressive multiple sclerosis (PMS); PIPE-307, a selective inhibitor of the M1 receptor ...

a novel oral NLRP3 inflammasome inhibitor in patients with Amyotrophic Lateral Sclerosis (ALS). Under the leadership of Principal Investigator Prof Merit Cudkowicz, MD, Director of the Sean M. Healey ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Many people living with multiple sclerosis (MS) experience speech issues. With MS, you can develop persistent speech difficulties, or you might have speech problems that come and go. You may find ...

The closures of three rural primary schools have been described as "devastating" - one year after they were given a reprieve. Parents of pupils at Balnamore Primary School in County Antrim said ...

Background/aims: Oro-pharyngeal dysfunction has been reported in Amyotrophic Lateral Sclerosis (ALS). We aimed to assess ALS patients upper gastrointestinal (GI) motor activity and GI symptoms ...